Compare EVO & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | EVO | UTL |
|---|---|---|
| Founded | 1993 | 1984 |
| Country | Germany | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 899.9M |
| IPO Year | 2021 | N/A |
| Metric | EVO | UTL |
|---|---|---|
| Price | $3.20 | $49.17 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 1 | 1 |
| Target Price | $7.00 | ★ $55.00 |
| AVG Volume (30 Days) | ★ 250.1K | 134.4K |
| Earning Date | 11-05-2025 | 02-09-2026 |
| Dividend Yield | N/A | ★ 3.72% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.85 |
| Revenue | ★ $887,396,457.00 | $502,000,000.00 |
| Revenue This Year | N/A | $5.98 |
| Revenue Next Year | $8.52 | $7.76 |
| P/E Ratio | ★ N/A | $17.00 |
| Revenue Growth | N/A | ★ 1.03 |
| 52 Week Low | $2.84 | $44.61 |
| 52 Week High | $4.80 | $59.99 |
| Indicator | EVO | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 54.56 | 50.59 |
| Support Level | $3.08 | $47.40 |
| Resistance Level | $3.18 | $49.54 |
| Average True Range (ATR) | 0.08 | 0.96 |
| MACD | 0.03 | -0.05 |
| Stochastic Oscillator | 92.31 | 46.01 |
Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.